跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,279 条关于
“muscarinic acetylcholine receptor M4”
全部
12,279
临床试验
5,894
药物
1,340
机构
30
资讯
5,015
2年前
Cerevel Therapeutics Advances Emraclidine Development for Alzheimer's-Related Dementia and Psychosis
10个月前
Neumora Therapeutics Initiates Phase 1 Trial for Second M4 Muscarinic Receptor Modulator NMRA-898
去年
Neurocrine Biosciences Advances Novel Muscarinic M4 Agonist to Phase 3 Trials for Schizophrenia
23天前
FDA Clears IND for Neurocrine and Nxera's Oral M1 Agonist NBI-1117567 in Alzheimer's Cognition
8个月前
Neurosterix Initiates Phase 1 Trial of NTX-253, Novel M4 Receptor Modulator for Schizophrenia Treatment
去年
MapLight Therapeutics Initiates Phase 2 Trial of Novel M1/M4 Muscarinic Agonist ML-007C-MA for Schizophrenia Treatment
去年
Neumora Therapeutics Initiates Phase 1 Trial of Novel M4 Receptor Modulator NMRA-861 for Schizophrenia
去年
FDA Approves Cobenfy, a Novel Muscarinic Receptor-Targeting Drug for Schizophrenia
去年
Xanomeline/Trospium Chloride (COBENFY™) Approved for Schizophrenia Treatment
2个月前
First In Vivo PET Evidence Reveals Widespread M1 Receptor Deficits in Living Schizophrenia Patients
第 1 页，共 502 页
上一页
下一页
